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A closed fracture was performed on the left tibia of 3-month-old Wistar rats weighing 250 to 350 g that were either healthy (N =
24) or made diabetic with alloxan (N = 24) to investigate the effect of alloxan-induced diabetes on the course of bone fracture
healing. Histomorphometric analysis of the fracture site was performed at 7, 14, 25, and 35 days. After 7 days, diabetic rats had
significantly less cartilage (P = 0.045) and greater fibrous connective (P = 0.006) tissue formation at the fracture site compared
to controls. In contrast, marked callus formation was seen in diabetic rats with significant osteogenesis (P = 0.011, P = 0.010,
P = 0.010, respectively, for 14, 25, and 35 days) and chondrogenesis (P = 0.028, P = 0.033, P = 0.019) compared to controls.
Radiographic analysis revealed a displaced fracture with poor bone fragment alignment and delayed consolidation at these
times in the diabetic group. The levels of alkaline phosphatase were significantly higher in diabetic rats at 25 days (P = 0.009).
These results suggest that the initial excessive formation of fibrous connective tissue associated with delay in chondrogenesis
and osteogenesis may not provide suitable stability of the fractured site, contributing to the inappropriate alignment of fragments
and an increase in the volume of callus in later stages of repair. The resulting displaced fracture in diabetic rats requires long
periods for remodeling and complete bone consolidation.
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Introduction
Diabetes mellitus is a metabolic disorder characterized
by disturbances in the metabolism of carbohydrates,
proteins and lipids as a result of absolute or moderate
insulin deficiency (1). Diabetes affects some 16 million
Americans, approximately 2-4% of the population, and is
responsible for over 40,000 deaths and 20,000 amputa-
tions annually in the United States. In Brazil, the preva-
lence of diabetes is similar, with the estimated number
of affected adults expected to rise to 11.6 million by the
year 2025. It is notable that 40% of carriers are unaware
that they have the disease (2-4).
Diabetes has been associated with an extensive list of
complications involving various tissues in the body, includ-
ing bone (1). Previous studies have shown a relationship
between diabetes and delayed fracture healing and bone
defects in human and animal models (5-13). Fracture
healing is a complex process, involving a cascade of
synthesis and activation of matrix- and cell-derived mol-
ecules that coordinate the restoration of mechanical stabil-
ity at the fracture site. Immediately after fracture, a he-
matoma forms to fill the fracture gap and the inflammatory
response is activated in the area surrounding the bone
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injury (14-17). The initial hematoma after injury is impor-
tant as a source of molecules that stimulate inflammation
and proliferation. Afterwards, the hematoma organizes
itself contributing to remodeling of the fractured ends of the
bone. This fusiform and predominantly uncalcified tissue,
called soft tissue callus or procallus, provides some an-
chorage between the ends of the fractured bone, but offers
no structural rigidity for weight bearing. Subsequently,
activated mesenchymal cells in the soft tissue and bone
surrounding the fracture line also differentiate into chon-
droblasts that produce the fibrocartilage and hyaline carti-
lage. The newly formed cartilage undergoes endochondral
ossification. Furthermore, the activated osteoprogenitor
cells deposit subperiosteal trabeculae of woven bone.
Finally, the process of remodeling, in which relatively dis-
organized woven bone is gradually replaced by more
mature lamellar bone, occurs over a period of weeks. In
this manner, the fratured ends are bridged by a bony callus
(16,17).
Several mechanisms have been proposed to explain
the greater incidence of delayed healing and non-union of
fractures in diabetes. These include reduction in blood
supply and angiogenesis (1), a more severe inflammatory
response (18,19), a decrease in collagen synthesis (6,20,
21), a disturbance in the mineralization process (9,11,12),
and an imbalance between bone resorption by osteoclasts
and bone deposition by osteoblasts (22-24). Another con-
tributing factor may be the advanced glycation end prod-
ucts, present in high levels in diabetic individuals, that
amplify inflammatory events (25) and delay wound healing
(26). In general, these mechanisms would be expected to
affect all stages of fracture healing.
Fracture healing and bone defects have been exten-
sively studied in a variety of diabetes models including
spontaneously diabetic BB/O(ttawa)K(arlsburg) rats (9-
12), BB Wistar rats (8) and streptozotocin-induced diabetic
rats (6,7). Alloxan exerts direct cytotoxic action on the
pancreatic islets, thereby eliminating the production of
insulin and causing severe hyperglycemia in the animal.
This situation is somewhat analogous to type 1 diabetes in
humans (27,28).
The purpose of the present study was to evaluate the
effects of alloxan-induced diabetes on the course of frac-
ture healing. We observed an initial excessive formation of




A total of 48 skeletally mature, male, 3-month-old Wistar
rats (Rattus norvegicus albinus) weighing 250 to 350 g
were used in this study. Rats were randomly assigned to
the diabetic or control group. The Animal Care Committee
at the University of Brasília approved all procedures per-
formed.
Alloxan-induced diabetes model
Diabetes was induced by a single intraperitoneal injec-
tion of 150 mg/kg monohydrated alloxan (Sigma, St. Louis,
MO, USA) dissolved in sterile 0.9% saline. Rats were
made to fast prior to alloxan administration. After 12 h, a
10% glucose solution was offered to the animals to prevent
hypoglycemia (27,28). After 72 h, blood samples were
collected from the tail vein of the animals for evaluation of
plasma glucose levels by the glucose-oxidase enzymatic
method using Accu-Chek Advantage (Boehringer, Ger-
many). Animals presenting glucose levels above 200 mg/
dL were included in the diabetic group (N = 24). The
animals presenting reversion of the signs of diabetes, i.e.,
those presenting glucose levels below 200 mg/dL, were
excluded from this study. The examinations were repeated
every 7 days to confirm maintenance of the glucose levels.
The pancreas was obtained from control and diabetic
animals for routine histopathological analysis.
Tibia fracture and specimen preparation
Using general anesthesia with ketamine (200 mg/kg)
and xylazine (10 mg/kg), closed fracture was inflicted
manually on the middle of the left tibia. The traces of all
fractures were similar, with no exposure to the outer envi-
ronment, as previously described (29). Given the need to
obtain fractures in as similar a manner as possible to
enable comparison during the trial, all fractures were per-
formed by the same investigator.
The control (N = 24) and diabetic (N = 24) groups were
sacrificed at 7, 14, 25 and 35 days (N = 6 at each time
following the fracture). For the histological studies, the
entire tibia was used after disarticulating it from the knee
and ankle. The specimens were fixed in 10% buffered
formaldehyde for 24 h, decalcified in 1% nitric acid for 24 h
and embedded in paraffin blocks. Approximately thirty 5-
µm thick sections were obtained from each paraffin block.
Approximately 6 hematoxylin and eosin-stained sections
containing the area of the fracture callus were selected
from each paraffin block for use in subsequent analyses.
Microscopic analysis was performed by two pathologists
who were blind to the identity of the specimens.
Histomorphometry
Three representative slides of six animals at each time
point were selected for histomorphometric analysis. Meas-
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urements of the areas of fibrous connective, cartilaginous
and bone tissues at the fracture callus were averaged in
six fields selected by systematic sampling in a stepwise
manner, moving the microscope stage from left to right and
then down and across in order to avoid measuring the
same area twice. The area of each tissue at 25X magnifi-
cation was obtained by drawing boundaries using the
software Image J (National Institutes of Health, USA).
Radiographic analysis
Radiographs were used to analyze the gross appear-
ance of the fracture callus and bone remodeling. Radio-
graphic analysis was performed by taking lateral radio-
graphs (Spectro 70X Electronic, Dabi Atlante, Ribeirão
Preto, SP, Brazil) at a setting of 0.6 kv for 15 s of both the
experimental (N = 6) and control (N = 5) legs at days 14, 21,
and 30 after fracture. The radiographs were developed on
Kodak 10-41 occlusal size 4 film (Eastman Kodak Co.,
Rochester, NY, USA). The bridging of the fracture callus
was described by two independent observers who were
blinded to the identity of the specimens.
Alkaline phosphatase activity
Blood samples (1 mL each) were taken by intracardiac
puncture before sacrifice on days 7, 14, 21, and 30, and
stored at -20°C until analysis. Serum concentration of alka-
line phosphatase (ALP) was measured with a commercially
available kit (Labtest Diagnóstica, Lagoa Santa, MG, Brazil).
ALP was measured colorimetrically and assayed by the
hydrolysis of thymolphthalein monophosphate in alkaline
buffer solution at 37°C. Absorbance of thymolphthalein was
determined at 590 nm. Results are reported as units (µmol
thymolphthalein released/min) per mL.
Statistical analysis
Data are reported as mean ± standard deviation (SD).
Comparative analysis was performed using the non-para-
metric Mann-Whitney test. All analyses were made using




Blood-glucose levels were significantly (P < 0.01) higher
(3-5 times) in diabetic rats than controls at all times before
and after fracture. An increase of glucose levels (1-2 times)
was observed after fracture in both groups. Consistent with
this, pancreatic islets exposed to alloxan demonstrated
disorganization, reduction of size and loss of architecture
in comparison with controls (data not shown). Treatment
with alloxan did not significantly affect body weight through-
out the experimental period (data not shown).
Histological and histomorphometric findings
On day 7, diabetic rats had significantly less bone (15.2
and 7.3% of total callus area for controls and diabetics,
respectively; P = 0.068) and cartilage (24.7 and 12.2% of
total callus area; P = 0.045), and demonstrated greater
fibrous connective tissue formation (31.5 and 55.4% of
total callus area; P = 0.006) at the fracture site (Figure 1).
In contrast, marked callus formation was seen after 14
and 25 days, with greater bone formation (26.5 and 52.1%
of total callus area, for controls and diabetics, respectively,
at 14 days, P = 0.011; 31.9 and 75.2% of total callus area
for controls and diabetics, respectively, at 25 days, P =
0.010). Moreover, significantly more cartilage was seen in
the diabetic group (30.2 and 51.1% of total callus area for
controls and diabetics at 14 days, P = 0.028; 9.1 and
20.9% of total callus area for controls and diabetics at 25
days, P = 0.033). On the other hand, an abrupt decline in
fibrous tissue formation was observed in diabetic rats,
Figure 1. Quantitative analysis of fibrous connective tissue (A), cartilage (B) and bone (C) formation at the sites of tibia fracture.
Tissue formation 7, 14, 25, and 35 days after tibia fracture was measured with image analysis-assisted histomorphometry of
hematoxylin and eosin-stained sections as described in Material and Methods. Normal controls (open bars) and alloxan-induced
diabetic rats (closed bars). Results are reported as mean ± SD for six specimens per mm2. *P < 0.05 compared to control (Mann-
Whitney test).
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resulting in a smaller area of fibrous connective tissue in
this group (13.8 and 3.3%, and 8.6 and 1.1% of total callus
area for controls and diabetics, respectively, at 14, P =
0.011, and 25 days, P = 0.019). At 21 days, the fracture
callus was formed mostly by the bone and cartilage in both
groups (Figure 1).
After 35 days, diabetic rats still demonstrated exten-
sive cartilage (7.2 and 20.6% of total callus area for control
and diabetics, respectively; P = 0.019) and bone formation
(54.6 and 77.4% of total callus area; P = 0.010), but no
difference in the fibrous connective tissue area (2.1 and
1.96% of total callus area; P = 0.286) was observed in
relation to controls (Figure 1).
Despite the differences in the callus area of fibrous
connective tissue, cartilage and bone at each time, the
callus configuration was observed to be similar in both
groups with identical peaks of formation for each tissue
occurring at 7 days for fibrous connective tissue, 14 days
for cartilage and 35 days for bone (Figure 1).
At day 7, new woven bone, indicative of intramembra-
nous ossification, was observed in controls at the inferior
margins of the fracture callus (Figure 2A), whereas mostly
fibrous connective tissue was noted at the fracture site of
the diabetic rats (Figure 2B). Interestingly, at day 21, the
trabecular bone of controls exhibited a greater number of
medullary spaces (Figure 2C) than the diabetic group
(Figure 2D).
Although alignment of the bone extremities slightly im-
proved when the closed tibia fractures were immobilized in a
plaster of Paris cast, similar histologic and histomorphomet-
ric results were obtained when comparing each group with
or without fracture immobilization (data not shown).
Radiographic findings
To characterize the bridging of the fracture callus, X-
rays were performed at days 14, 25, and 35. On day 14, the
griding size of the fracture callus was larger in control rats
(Figure 3A) compared to diabetic rats (Figure 3B). On day
25, the progressive consolidation of the fracture gap in the
diabetic group was not clearly recognizable when com-
pared with the controls. A bone bridge was observed
between proximal and distal bone fragments adjacent to
the fracture in the control group (Figure 3C). In contrast, a
displaced fracture with poor alignment of bone fragments
was observed in the diabetic rats (Figure 3D). On day 35,
radiographs showed more rapid reconstitution of cortices
in controls (Figure 3E,F).
Grossly, no leg length discrepancy or limitation of move-
ment was noted between diabetics and controls at days
14, 25, or 35 after fracture.
Figure 2. Hematoxylin and eosin
staining of fracture callus for controls
[(A) day 7, (C) day 21], and alloxan-
induced diabetic rats [(B) day 7, (D)
day 21]. Ft = end of fractured tibia;
Tb = trabecular bone; Fc = fibrous
connective tissue; Ca = cartilaginous
tissue. Original magnification = 25X.
Bar = 10 µm.
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Alkaline phosphatase activity
Consistent with increased osteogenesis in diabetic
rats from 14 days, the levels of ALP were significantly
higher in this group at 14 (P = 0.06) and 25 (P = 0.009) days
(Figure 4). Moreover, the serum ALP levels of diabetic rats
correlated positively with bone tissue formation (Pearson
correlation, R2 = 0.526; P < 0.01). The ALP levels of
diabetic rats that did not undergo tibia fracture were similar
to those of the control group (data not shown).
Discussion
Consistent with previous clinical and experimental data
(5-13), we found that diabetes delayed fracture healing in
a rat model of closed fracture. This delay was initiated at
early stages of healing, demonstrated by the development
of abundant soft tissue formation (almost two times greater
in diabetic rats than in controls) and a significant deficiency
of chondrogenesis and osteogenesis in the fracture site of
the diabetic group. As mechanical stability of the fracture
callus was restored through endochondral and intramem-
branous ossification, we can assume that the initial impair-
ment of chondrogenesis and osteogenesis observed in
diabetic rats contributed to the low stability of the fracture
site and inappropriate alignment of fragments of this group,
as shown by radiographic analysis. Furthermore, the frac-
ture callus in diabetes has decreased mechanical strength,
which has been associated with changes in collagen ex-
pression (6,20,21), chondrocyte maturation (21) and re-
tarded mineralization (11-12). The disjointing of bone frag-
ments enlarges the volume of the callus by increasing
osteogenesis and chondrogenesis in the latter stages.
Consequently, long time periods are required for remodel-
ing and complete bone consolidation following delayed
union, non-union, or pseudoarthrosis. Taken together, these
results suggest that formation of the bony callus in the
diabetic group was delayed, but not inhibited. By days 14,
25 and 35, the area of cartilage and bone in the fracture
callus was larger in diabetics than in controls. Persistence
of a large cartilaginous callus, together with trabecular
bone with sparse spacing, suggested delayed healing in
diabetics and a less mature fracture callus in these ani-
mals.
Consistent with the increase of osteogenesis in the
diabetic group, the serum levels of ALP, a marker of bone
formation, were also significantly increased in this group.
We also found a positive correlation between the levels of
ALP in serum with bone formation in diabetic rats. These
results may suggest that alloxan-induced diabetes affects
the process of matrix formation and mineralization in the
Figure 4. Serum alkaline phosphatase (ALP) of diabetic and
control rats 7, 14, 25, and 35 days after fracture. Serum concen-
tration of ALP was measured colorimetrically as described in
Material and Methods. Results are reported as means ± SD in
units (µmol thymolphthalein released/min) per mL. *P = 0.009
compared to respective control (Mann-Whitney test).
Figure 3. Lateral radiographs of fractured
tibias for controls (A, day 14, C, day 25, E,
day 35), and diabetics (B, day 14, D, day
28, E, day 35).
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bone, as reported in other diabetes models (6-12,21-24).
The effects of alloxan-induced diabetes on bone tissue
include decreased trabecular bone volume and cortical
width, increased bone collagen glycosylation and de-
creased rate of bone resorption (30). We observed that
alloxan-treated rats showed morphologic alterations in the
pancreatic islets (27,28). Controlled insulin therapy may
revert the disorders in fracture repair observed in the
poorly compensated diabetic metabolic state (8,11,12,21);
however, in the usual clinical situation, a diabetic patient
with insulin-dependent type 1 diabetes treated with insulin
may still suffer from an overall poor diabetic metabolic
state with an uncontrollable or hardly controllable blood-
glucose level and a high and sometimes changing insulin
requirement. Thus, glycemic control in humans is pivotal
for improving or increasing the speed of the healing pro-
cess after injury and decreasing the significant morbidity
associated with uncontrollable blood-glucose levels dur-
ing fracture healing.
The present study, to our knowledge, represents the
first histomorphometric analysis of the effect of alloxan-
induced diabetes on bone fracture healing. Our findings
suggest that the diabetic state induced by alloxan delays
chondrogenesis and osteogenesis in the first stages of
fracture healing. As a consequence, there is inappropriate
stability of fractured fragments, which contributes to the
increase in the volume of callus in later stages and re-
quires long periods of time for remodeling and complete
bone consolidation.
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